Berenberg Bank raised a price target and gave a 'hold' rating on Eli Lilly and Company, alongside filing required reports with the SEC.
3 reports, 3 independent
Updated Jul 21
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Berenberg Bank raised a price target and gave a 'hold' rating on Eli Lilly and Company, alongside filing required reports with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Eli Lilly and Company faces a lawsuit over alleged misleading advertising claims as financial institutions provide research reports and price targets.1 source
Berenberg Bank adjusted price targets and ratings for Eli Lilly and Company.1 source
Berenberg Bank raised a price target and filed required reports regarding share purchases for Eli Lilly.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
Berenberg Bank
German private bank based in Hamburg
-
SEC
Slovak company
Related events
- Analyst firms provided ratings and price targets for Anglo American plc.
- Berenberg Bank reiterated a 'buy' rating for Next 15 Group plc, with consensus ratings reported by MarketBeat.
- Berenberg Bank reduced its target price and maintained a buy rating for Strix Group Plc, based on consensus data reported by MarketBeat.
- Eli Lilly and Company filed institutional holdings reports with the SEC, while Bank of America raised price targets on the stock.
- Berenberg Bank, headquartered in London, UK, provides buy ratings and price targets as of September 1, 2026, involving Jupiter Fund Management.